Noticias sobre VIH/SIDA

Indonesia: tackling HIV in one of the world’s fastest-growing epidemics

Aidsmap news - English - Mar, 04/09/2018 - 9:00am
A prospective study that recruited a significant proportion of people newly diagnosed with HIV in four locations in Indonesia and offered them immediate antiretroviral therapy (ART) found that only 35% of them were still on ART and virally suppressed at the end of the year. The study, published in the Lancet HIV,
Categorías: VIH/SIDA

AIDS 2018: Se observa un aumento de ITS entre hombres gais y otros HSH que reciben profilaxis preexposición al VIH

gTt-VIH - La noticia del día - Lun, 03/09/2018 - 9:26am

Los resultados del estudio PrEPX –un estudio de demostración sobre la profilaxis preexposición frente al VIH (PrEP) realizado en Victoria (Australia)– han revelado un aumento significativo de infecciones de transmisión sexual (ITS) bacterianas en hombres gais, bisexuales y otros hombres que practican sexo con hombres (HSH). Sin embargo, estas nuevas infecciones se concentraron en un subgrupo de participantes que estaban recibiendo PrEP. Además, se registró un aumento en el número de pruebas de ITS realizadas lo que atenuó el aumento general en la incidencia. Estos resultados se dieron a conocer durante la 22 Conferencia Internacional del Sida (AIDS 2018), celebrada a finales de julio en Ámsterdam (Países Bajos).

Categorías: VIH/SIDA

Some antiretroviral regimens associated with pre-term birth and low birth weight

Aidsmap news - English - Lun, 03/09/2018 - 9:20am
Exposure to protease inhibitor based regimens and non-nucleoside reverse transcriptase inhibitor (NNRTI) based regimens may each be linked to low birth weight and pre-term births in infants of mothers living with HIV in lower-income countries, but the choice of nucleoside reverse transcriptase inhibitor (NRTI) backbone also appears to influence this risk, according to a
Categorías: VIH/SIDA

One in three women in US survey have negative attitudes towards PrEP

Aidsmap news - English - Vie, 31/08/2018 - 9:30am
A survey conducted by Planned Parenthood in the US state of Connecticut has found that although less than a quarter of women attending their clinics were aware of PrEP, they generally expressed positive views about it. Only about a third of respondents endorsed the view that people would assume they were promiscuous or were
Categorías: VIH/SIDA

Appropriate pain management may have role in key HIV treatment outcomes, suggests US research

Aidsmap news - English - Jue, 30/08/2018 - 9:30am
Long-term opioid therapy for HIV-positive patients with chronic pain could be an important addition to antiretroviral therapy, according to US research published in the Journal of Acquired Immune Deficiency Syndromes.  Among patients reporting chronic pain of moderate intensity or worse, long-term opioid therapy (LTOT) increased the chances of viral suppression by half. The research also
Categorías: VIH/SIDA

The work of a couple: how gay men in relationships come to trust that “Undetectable = Untransmittable”

Aidsmap news - English - Mié, 29/08/2018 - 9:00am
Having a relationship based on trust, commitment and familiarity helps Australian gay men rely on undetectable viral load as a means of HIV prevention, according to interviews with HIV-positive and HIV-negative members of serodifferent couples. Confidence in the protective power of an undetectable viral load is also strengthened by receiving consistent test results
Categorías: VIH/SIDA

PrEP for female sex workers: non-judgmental attitudes and community involvement are keys to success

Aidsmap news - English - Mar, 28/08/2018 - 9:10am
Several studies presented at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam last month detailed very different approaches to introducing PrEP to female sex workers (FSWs) as part of combination HIV prevention.The studies range from an innovative community-run PrEP study among FSWs in two locations in India, which achieved very high rates of adherence,
Categorías: VIH/SIDA

Europe close to meeting UNAIDS 90-90-90 target but considerable variability between countries

Aidsmap news - English - Lun, 27/08/2018 - 9:00am
The European region of the World Health Organization is close to achieving the UNAIDS 90-90-90 target, according to research published in the Journal of Acquired Immune Deficiency Syndromes. Data collected in 2016 showed that, overall, 81% of patients with HIV had been diagnosed, 84% of diagnosed patients were on antiretroviral therapy (ART) and 88% of
Categorías: VIH/SIDA

Dolutegravir-based ART effective and safe for HIV-positive people taking standard TB treatment

Aidsmap news - English - Vie, 24/08/2018 - 9:50am
Dolutegravir-based antiretroviral therapy (ART) is effective and safe when taken at the same time as standard tuberculosis (TB) therapy, according to an international study presented at the 22nd International AIDS Conference (AIDS 2018), held in Amsterdam in July. After 48 weeks of therapy, 75% of people had an undetectable viral load, comparable to the
Categorías: VIH/SIDA

Breastfeeding with undetectable viral load: genuine uncertainty on risk should be communicated to women with HIV, say Swiss doctors

Aidsmap news - English - Jue, 23/08/2018 - 9:20am
Women with HIV on effective antiretroviral treatment in higher-income settings who have undetectable viral load should be supported to make their own decisions about breastfeeding based on a full discussion of the risks and benefits, rather than being discouraged from breastfeeding, a group of Swiss doctors has concluded after reviewing the available evidence. Their opinion
Categorías: VIH/SIDA

Neuropsychiatric side-effects lead only 1 in 40 to drop dolutegravir, French study shows

Aidsmap news - English - Mié, 22/08/2018 - 9:50am
A large French study of people taking HIV treatment that contained an integrase inhibitor found that approximately one person in forty who started treatment with dolutegravir stopped taking the drug due to neuropsychiatric side-effects, a significantly higher rate than observed in people taking either elvitegravir or raltegravir, a poster presentation at last month’s 22nd International
Categorías: VIH/SIDA

Giving gay men self-test kits increases testing by 50% - but STI tests decrease

Aidsmap news - English - Mar, 21/08/2018 - 9:00am
Gay men who were offered HIV home-testing kits took 50% more tests than men who only took HIV tests at clinics or community organisations, a randomised controlled study from Seattle in the USA has found. The men who could self-test took fewer tests for sexually transmitted infections (STIs), though it is not completely clear whether
Categorías: VIH/SIDA

UK research shows that black patients of West African and Caribbean origin have higher rates of chronic kidney disease

Aidsmap news - English - Lun, 20/08/2018 - 11:30am
The risk of chronic and end-stage kidney disease among HIV-positive patients of African ethnicity varies according to the region of origin and is highest among those of West African descent, according to UK research published in the Journal of Infectious Diseases. A low CD4 cell count and ongoing viral replication were also risk factors
Categorías: VIH/SIDA

Starting treatment on the day of HIV diagnosis is acceptable and feasible for Thai patients

Aidsmap news - English - Vie, 17/08/2018 - 9:20am
Starting treatment on the day of HIV diagnosis is acceptable and feasible for Thai patients, and people who started treatment very soon after diagnosis were more than twice as likely to have an undetectable viral load within 300 days of diagnosis when compared to people managed under existing Thai guidelines, the 22nd International AIDS
Categorías: VIH/SIDA

One in nine people may be able to control their viral load after stopping treatment, US study finds

Aidsmap news - English - Jue, 16/08/2018 - 11:00am
A US collaboration that pooled data from 14 scientific studies containing between them more than 600 HIV-positive patients has found that 67 of them were able to maintain or re-establish a viral load below 400 copies/ml for at least 48 weeks after their antiretroviral therapy (ART) was stopped. This is the first large study
Categorías: VIH/SIDA

People taking a protease inhibitor who have heart failure have an increased mortality risk, study claims

Aidsmap news - English - Jue, 16/08/2018 - 9:30am
HIV-positive patients who are taking antiretroviral therapy and are hospitalised due to heart failure are more likely to die because of cardiovascular disease if they are taking a regimen containing a protease inhibitor, according to research conducted in the United States and published in the Journal of the American College of Cardiology. Mortality and hospital
Categorías: VIH/SIDA

HIV and chronic HCV co-infection prevalence in England highest among MSM

Aidsmap news - English - Mié, 15/08/2018 - 9:40am
Men who have sex with men (MSM) make up the majority of people with chronic hepatitis C virus (HCV) who have co-infection with HIV, according to data from Public Health England (PHE) published in HIV Medicine. Approximately two-thirds of prevalent HIV infections among people with chronic HCV involved MSM, and the majority of these people
Categorías: VIH/SIDA

Treatment with modern antiretrovirals doesn't increase the risk of hypertension

Aidsmap news - English - Mar, 14/08/2018 - 9:40am
There is no strong evidence that treatment with antiretrovirals significantly increases the risk of hypertension, investigators from the D:A:D study report in HIV Medicine.  After taking into account demographic and traditional risk factors, only two older anti-HIV drugs had a significant association with hypertension. “Using data from a large, heterogeneous cohort with information on a
Categorías: VIH/SIDA

PrEP use taking off in Thailand and Vietnam

Aidsmap news - English - Lun, 13/08/2018 - 9:10am
PrEP use is accelerating among men who have sex with men (MSM) and transgender women (TGW) in two south-east Asian countries where it is receiving funding and government support, the AIDS2018 conference heard two weeks ago. As with PrEP in other settings, one of the challenges is retention; in Thailand only half of the
Categorías: VIH/SIDA

ONUSIDA celebra el nombramiento de Michelle Bachelet como alta comisionada de las Naciones Unidas para los Derechos Humanos

UNAIDS | Press Statements - Vie, 10/08/2018 - 11:15am
ONUSIDA celebra el nombramiento de Michelle Bachelet, expresidenta de Chile, como jefa de derechos humanos de las Naciones Unidas.
Categorías: VIH/SIDA

Páginas